ACETAMINOPHEN; IBUPROFEN Drug Patent Profile
✉ Email this page to a colleague
When do Acetaminophen; Ibuprofen patents expire, and what generic alternatives are available?
Acetaminophen; Ibuprofen is a drug marketed by Aurobindo Pharma Ltd and is included in one NDA.
The generic ingredient in ACETAMINOPHEN; IBUPROFEN is acetaminophen; ibuprofen. There are sixty-six drug master file entries for this compound. Thirty-six suppliers are listed for this compound. Additional details are available on the acetaminophen; ibuprofen profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Acetaminophen; Ibuprofen
A generic version of ACETAMINOPHEN; IBUPROFEN was approved as acetaminophen; ibuprofen by L PERRIGO CO on February 28th, 2023.
Summary for ACETAMINOPHEN; IBUPROFEN
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Finished Product Suppliers / Packagers: | 1 |
Clinical Trials: | 235 |
Formulation / Manufacturing: | see details |
DailyMed Link: | ACETAMINOPHEN; IBUPROFEN at DailyMed |
Recent Clinical Trials for ACETAMINOPHEN; IBUPROFEN
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Korea University Guro Hospital | Phase 4 |
Kyongbo Pharmaceutical Co.,Ltd | Phase 4 |
Novo Nordisk A/S | Phase 1 |
Anatomical Therapeutic Chemical (ATC) Classes for ACETAMINOPHEN; IBUPROFEN
US Patents and Regulatory Information for ACETAMINOPHEN; IBUPROFEN
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Aurobindo Pharma Ltd | ACETAMINOPHEN; IBUPROFEN | acetaminophen; ibuprofen | TABLET;ORAL | 218359-001 | Mar 26, 2024 | OTC | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |